Anta Biotechnologies Corporation

San Diego, CA

UEI
U1B4HRNRXEM9
CAGE
9JJL0
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Minority Owned Business
  • For Profit Organization
  • Woman Owned Business
  • Subcontinent Asian (Asian-Indian) American Owned
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
9276 Scranton Rd #500, San Diego, CA 92121, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Anta Biotechnologies Corporation's 3 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Sbir 1AUTOMATED DNA extraction in space Contract · 80NSSC25C0139 Shared Services Center $174,499
Sbir phase II: autonomous system for DNA sequencing prep in space and austere environments -the broader… Grant · 2533096 National Science Foundation $1,229,393
Sbir phase i: autonomous system for DNA sequencing prep in space and austere environments -the broader impact/commercial… Grant · 2344191 National Science Foundation $275,000

About Anta Biotechnologies Corporation

Anyglabs, Inc. is a minority-owned, woman-owned, and Subcontinent Asian American-owned small business located in San Diego, California, specializing in advanced biotechnology solutions with a primary focus on developing innovative DNA extraction and sequencing technologies for space and austere environments. The company is registered in the System for Award Management (SAM.gov) and has demonstrated a strategic approach to developing cutting-edge scientific technologies that address complex challenges in molecular diagnostics and research.

Through its federal contract awards, Anyglabs, Inc. has secured a Small Business Innovation Research (SBIR) Phase I contract with a civilian federal agency for developing an "AUTOMATED DNA EXTRACTION IN SPACE" solution. The contract, valued at $174,499.00, is a firm-fixed-price definitive contract set aside for small businesses, with a performance period ending on March 27, 2026. The contract represents the company's capabilities in creating innovative scientific solutions specifically designed for challenging research environments, with a particular emphasis on space-related technological advancements.

Anyglabs, Inc. has been successful in obtaining federal grant awards from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships program, specifically through SBIR Phase I and Phase II grants. These grants, totaling approximately $1.5 million, support the development of an autonomous, miniaturized system for DNA extraction and preparation for sequencing in space and austere environments. The grant projects aim to disrupt the global DNA sequencing market by creating a portable, automated solution for extracting DNA from various biosamples, with potential applications in medical research, environmental monitoring, and space exploration. The company's long-term vision includes generating nearly $20 million in revenue by the third year of production and democratizing access to advanced molecular diagnostic technologies.

Quick answers

What is Anta Biotechnologies Corporation's UEI?

Anta Biotechnologies Corporation's Unique Entity ID (UEI) in SAM.gov is U1B4HRNRXEM9.

What is Anta Biotechnologies Corporation's CAGE code?

Anta Biotechnologies Corporation's CAGE code is 9JJL0.

What is Anta Biotechnologies Corporation's primary NAICS code?

Anta Biotechnologies Corporation's primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Anta Biotechnologies Corporation located?

Anta Biotechnologies Corporation's physical address in SAM.gov is 9276 Scranton Rd #500, San Diego, CA 92121, USA.

Is Anta Biotechnologies Corporation registered in SAM.gov?

Yes. Anta Biotechnologies Corporation's SAM.gov registration is active through January 7, 2027.

What is Anta Biotechnologies Corporation's most recent federal award?

Anta Biotechnologies Corporation's most recent federal contract award is Sbir 1AUTOMATED DNA extraction in space (80NSSC25C0139), from Shared Services Center, on September 29, 2025.

On GovTribe

See Anta Biotechnologies Corporation's full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors